Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001415889-25-022005
Filing Date
2025-08-14
Accepted
2025-08-14 17:57:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10864
  Complete submission text file 0001415889-25-022005.txt   12662
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121
Business Address 10955 ALEXANDRIA WAY SUITE 100 SAN DIEGO CA 92121 (858) 766-9912
Boundless Bio, Inc. (Subject) CIK: 0001782303 (see all company filings)

EIN.: 830751369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94492 | Film No.: 251221469
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)